Distillery Therapeutics


<div class="articleContainer">
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title distillery_title" doc-editable="text" data-component-id="doc-1ef7l992d0">Protease inhibitor SERPINB9 as a melanoma, breast cancer target</h1><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1ef7l9he70">
    <span class="ng-tns-c17-4" doc-editable="text">By Claire Quang, Staff Writer</span>
</div><div class="date" data-component-id="doc-1ef7l9jmf0">
  <span class="byline" doc-editable="text"></span>
</div></div></div></div>


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

Brigham and Women's Hospital

Harvard Medical School

DISEASE CATEGORY: CancerINDICATION: Melanoma; breast cancer......

Cancer

Melanoma

Breast cancer

Serpin family B member 9 (SERPINB9)

Protease inhibitor SERPINB9 as a melanoma, breast cancer target

DISEASE CATEGORY: Cancer<br/>INDICATION: Melanoma; breast cancer Inhibiting SERPINB9, a serine protease inhibitor, could treat melanoma and breast cancer. In a melanoma mouse model, tumor-specific